Dr.  

Craig Leonardi


Presentations

Impact of Body-Weight on the Efficacy and Exposure-Response of Risankizumab in Patients with Moderate-to-Severe Plaque Psoriasis: An Integrated Analysis of Two Phase 3 Clinical Trials 09 October 2019 00:00 - 00:00

Abstracts

Impact of Body-Weight on the Efficacy and Exposure-Response of Risankizumab in Patients with Moderate-to-Severe Plaque Psoriasis: An Integrated Analysis of Two Phase 3 Clinical Trials Psoriasis More